Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
745.76
636.91
623.87
540.64
529.38
501.84
443.99
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
745.76
636.91
623.87
540.64
529.38
501.84
443.99
Raw Material Cost
194.31
161.96
155.45
127.51
130.26
100.18
90.60
Purchase of Finished goods
0.00
0.00
0.02
0.02
0.07
0.03
0.23
(Increase) / Decrease In Stocks
-1.36
-10.10
-10.89
4.28
-20.61
-1.16
-9.92
Employee Cost
162.29
141.54
127.78
114.80
103.96
87.11
80.19
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
-0.01
0.00
-0.01
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
161.45
149.07
147.05
137.59
114.29
84.08
80.56
Total Expenditure (Excl Depreciation)
516.69
442.47
419.41
384.19
327.97
270.23
241.66
Operating Profit (PBDIT) excl Other Income
229.07
194.44
204.46
156.45
201.41
231.61
202.33
Other Income
34.83
33.04
36.66
25.46
6.42
8.85
5.64
Operating Profit (PBDIT)
263.90
227.48
241.12
181.91
207.83
240.46
207.97
Interest
2.63
3.56
2.93
2.42
1.80
1.61
3.04
Exceptional Items
11.36
0.00
-15.13
-4.06
0.00
0.00
0.00
Gross Profit (PBDT)
272.63
223.92
223.06
175.43
206.03
238.85
204.93
Depreciation
40.09
36.56
35.24
35.03
34.98
28.72
25.78
Profit Before Tax
232.54
187.36
187.82
140.39
171.06
210.13
179.16
Tax
58.93
53.39
50.87
36.52
47.26
58.85
46.11
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
173.61
133.97
136.95
103.87
123.80
151.29
133.05
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
173.61
133.97
136.95
103.87
123.80
151.29
133.05
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-4.89
-2.86
-3.65
1.77
-4.22
-5.36
-3.76
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
168.72
131.12
133.31
105.64
119.58
145.93
129.29
Equity Capital
22.39
22.38
22.37
22.37
22.36
22.35
22.34
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
1,609.57
1,398.49
1,301.76
1,212.70
1,066.23
948.59
817.32
Earnings per share (EPS)
15.07
11.72
11.92
9.44
10.7
13.06
11.57
Diluted Earnings per share
15.06
11.71
11.92
9.45
10.68
13.04
11.56
Operating Profit Margin (Excl OI)
30.72%
30.53%
32.77%
28.94%
38.05%
46.15%
45.57%
Gross Profit Margin
36.56%
35.16%
35.75%
32.45%
38.92%
47.59%
46.16%
PAT Margin
23.28%
21.03%
21.95%
19.21%
23.39%
30.15%
29.97%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 17.09% vs 2.09% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 28.68% vs -1.64% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 17.81% vs -4.90% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -26.12% vs 21.50% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Advanced Enzyme With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
745.76
0
745.76
Other Operating Income
0.00
0.00
0.00
Total Operating income
745.76
0
745.76
Raw Material Cost
194.31
0
194.31
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
-1.36
0
-1.36
Employee Cost
162.29
0
162.29
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
161.45
0.00
161.45
Total Expenditure (Excl Depreciation)
516.69
0
516.69
Operating Profit (PBDIT) excl Other Income
229.07
0.00
229.07
Other Income
34.83
0
34.83
Operating Profit (PBDIT)
263.90
0
263.90
Interest
2.63
0
2.63
Exceptional Items
11.36
0
11.36
Gross Profit (PBDT)
272.63
0
272.63
Depreciation
40.09
0
40.09
Profit Before Tax
232.54
0
232.54
Tax
58.93
0
58.93
Provisions and contingencies
0.00
0
0.00
Profit After Tax
173.61
0
173.61
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
173.61
0
173.61
Share in Profit of Associates
0.00
0
0.00
Minority Interest
-4.89
0
-4.89
Other related items
0.00
0.00
0.00
Consolidated Net Profit
168.72
0
168.72
Equity Capital
22.39
0
22.39
Face Value
2.00
0
0.00
Reserves
1,609.57
0
1,609.57
Earnings per share (EPS)
15.07
0
15.07
Diluted Earnings per share
15.06
0
15.06
Operating Profit Margin (Excl OI)
30.72%
0%
0.00
30.72%
Gross Profit Margin
36.56%
0%
0.00
36.56%
PAT Margin
23.28%
0%
0.00
23.28%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 745.76 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 17.09% vs 2.09% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 168.72 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 28.68% vs -1.64% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 229.07 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 17.81% vs -4.90% in Mar 2025
Annual - Interest
Interest 2.63 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -26.12% vs 21.50% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 30.72%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025






